FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
|Videos|June 24, 2014
The Benefit of Data Analytics for Specialty Pharmacy
Author(s)Davy James, Associate Editor
Howard Barsky, chief information officer for Armada Health Care, discusses the benefits of enhanced data analytics programs and how they can benefit specialty pharmacies.
Advertisement
Howard Barsky, chief information officer for Armada Health Care, discusses the benefits of enhanced data analytics programs and how they can benefit specialty pharmacies.
Advertisement
Related to this article
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
The once-daily tablet is the third approved treatment for fibrodysplasia ossificans progressiva (FOP), with CYP3A4 and metformin interaction guidance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
4
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
5